Syngene International Limited

BSE:539268 Stock Report

Market Cap: ₹282.8b

Syngene International Past Earnings Performance

Past criteria checks 4/6

Syngene International has been growing earnings at an average annual rate of 7.1%, while the Life Sciences industry saw earnings growing at 8.8% annually. Revenues have been growing at an average rate of 14.9% per year. Syngene International's return on equity is 12.9%, and it has net margins of 14%.

Key information

7.1%

Earnings growth rate

6.9%

EPS growth rate

Life Sciences Industry Growth11.2%
Revenue growth rate14.9%
Return on equity12.9%
Net Margin14.0%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Syngene International makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BSE:539268 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2335,6615,0029,5160
30 Sep 2334,9854,9849,4150
30 Jun 2333,5654,8399,2320
31 Mar 2331,9294,6448,9390
31 Dec 2229,5664,3348,1000
30 Sep 2228,1214,2777,8800
30 Jun 2226,5423,9247,6540
31 Mar 2226,0423,9587,5040
31 Dec 2125,0474,0867,4610
30 Sep 2124,4784,0687,3330
30 Jun 2123,5724,2427,0990
31 Mar 2121,8434,0496,7920
31 Dec 2021,3303,6456,6190
30 Sep 2020,6763,5416,3820
30 Jun 2020,1263,9816,0880
31 Mar 2020,1194,1216,0060
31 Dec 1919,3853,9205,7800
30 Sep 1918,8653,8725,4460
30 Jun 1918,4053,3745,2770
31 Mar 1918,2563,3165,0320
31 Dec 1817,0083,1604,7330
30 Sep 1816,2143,1104,5020
30 Jun 1815,3803,0964,2900
31 Mar 1814,2313,0544,0730
31 Dec 1713,0532,9933,7220
30 Sep 1712,4972,9173,5650
30 Jun 1712,1752,8953,3950
31 Mar 1712,0092,8733,2740
31 Dec 1612,4112,6823,2200
30 Sep 1611,8942,6063,0210
30 Jun 1611,4792,3442,8260
31 Mar 1611,0702,4082,6770
31 Dec 1510,2352,1032,79866
30 Sep 159,7131,9642,70966
30 Jun 159,0171,8432,2730
31 Mar 158,5991,7502,1860
31 Mar 146,9951,3391,9940
31 Mar 135,5001,0211,5290

Quality Earnings: 539268 has high quality earnings.

Growing Profit Margin: 539268's current net profit margins (14%) are lower than last year (14.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 539268's earnings have grown by 7.1% per year over the past 5 years.

Accelerating Growth: 539268's earnings growth over the past year (15.4%) exceeds its 5-year average (7.1% per year).

Earnings vs Industry: 539268 earnings growth over the past year (15.4%) exceeded the Life Sciences industry 0.9%.


Return on Equity

High ROE: 539268's Return on Equity (12.9%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.